The role of epicardial fat in the pathogenesis of coronary heart disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045905

Enrollment

Unknown

Registered

2021-04-27

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

Case series:N/A

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Coronary artery bypass grafting due to coronary heart disease; 2.Surgical patients with rheumatic heart disease undergoing valve replacement.

Exclusion criteria

Exclusion criteria: 1. The patient was pregnant; 2. History of tumor and / or chemoradiotherapy; 3. Glucocorticoids were used in recent 3 months; 4. Severe hepatic and renal insufficiency; 5. Autoimmune diseases and other infectious diseases; 6. Immunosuppressants after organ transplantation.

Design outcomes

Primary

Measure	Time frame
Epicardial adipose tissue;	—

Secondary

Measure	Time frame
Subcutaneous adipose tissue;	—

Countries

China

Contacts

Public ContactPi-xiong Su, Lei Zhao

Beijing Chaoyang Hospital, Capital Medical University

supixiong1130@163.com+86 13910719885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026